Fablyn

Fablyn

Marketed minn: Dr. Friedrich Eberth Arzneimittel GmbH
Ingredjent attiv: Lasofoxifene tartrate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fabrazyme

Fabrazyme

Marketed minn: Genzyme Europe B.V.
Ingredjent attiv: agalsidase beta

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fampyra

Fampyra

Marketed minn: Blogen Netherlands B.V. 
Ingredjent attiv: Fampridine

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fareston

Fareston

Marketed minn: Orion Corporation
Ingredjent attiv: toremifene

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Farydak

Farydak

Marketed minn: Novartis Europharm Limited
Ingredjent attiv: panobinostat lactate anidru

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Faslodex

Faslodex

Marketed minn: AstraZeneca AB
Ingredjent attiv: fulvestrant

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fasturtec

Fasturtec

Marketed minn: Sanofi-aventis groupe 
Ingredjent attiv: rasburicase

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fendrix

Fendrix

Marketed minn: GlaxoSmithKline Biologicals S.A.
Ingredjent attiv: antigen tal-wiċċ ta 'l-epatite B

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Feraccru

Feraccru

Marketed minn: Shield TX (UK) Limited
Ingredjent attiv: Maltol ferriku

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ferriprox

Ferriprox

Marketed minn: Apotex Europe BV
Ingredjent attiv: Deferiprone

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fertavid

Fertavid

Marketed minn: Merck Sharp & Dohme B.V. 
Ingredjent attiv: follitropin beta

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fexeric

Fexeric

Marketed minn: Keryx Biopharma UK Ltd
Ingredjent attiv: kumpless ta 'koordinazzjoni taċ-ċitrat ferriku

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fiasp

Fiasp

Marketed minn: Novo Nordisk A/S
Ingredjent attiv: insulin aspart

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Filgrastim Hexal

Filgrastim Hexal

Marketed minn: Hexal AG
Ingredjent attiv: filgrastim

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Filgrastim Ratiopharm

Filgrastim Ratiopharm

Marketed minn: Ratiopharm GmbH
Ingredjent attiv: filgrastim

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Firazyr

Firazyr

Marketed minn: Shire Pharmaceuticals Ireland Limited
Ingredjent attiv: icatibant

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Firdapse (previously Zenas)

Firdapse (previously Zenas)

Marketed minn: BioMarin International Limited
Ingredjent attiv: amifampridine

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Firmagon

Firmagon

Marketed minn: Ferring Pharmaceuticals A/S
Ingredjent attiv: degarelix

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Flebogamma Dif (previously Flebogammadif)

Flebogamma Dif (previously Flebogammadif)

Marketed minn: Instituto Grifols S.A.
Ingredjent attiv: L-immunoglobulina normali umana

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Flixabi

Flixabi

Marketed minn: Samsung Bioepis NL B.V.
Ingredjent attiv: infliximab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fluenz

Fluenz

Marketed minn: MedImmune LLC
Ingredjent attiv: Reassortant-virus tal-influwenza (ħaj attenwat) tar-razez li ġejjin:/California/7/2009 (H1N1)pdm09 bħal strejn, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fluenz Tetra

Fluenz Tetra

Marketed minn: AstraZeneca AB
Ingredjent attiv: reassortant-virus tal-influwenza (ħaj attenwat) ta'dawn l-erba'razez:/California/7/2009 (H1N1)pdm09 - like strain(A/Bolivja/559/2013, il-MEDI 255962)A/Hong Kong/4801/2014 (H3N2) like strain(A/New Caledonia/71/2014, MEDI 263122)B/Brisbane/60/2008 - like strain(B/Brisbane/60/2008, MEDI 228030)B/kulħadd jinstemgħu/3073/2013 - like strain(B/kulħadd jinstemgħu/3073/2013, il-MEDI 254977)

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Focetria

Focetria

Marketed minn: Novartis Vaccines and Diagnostics S.r.l.
Ingredjent attiv: Influwenza avjana antigens tal-mikrobu tal-wiċċ (haemagglutinin u neuraminidase) ta ' nisel: A/California/7/2009 (H1N1) - miġjuba strain użat NYMC X - microgragms ta ' 181 7.5 għal kull doża ta ' 0.5 ml

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Foclivia

Foclivia

Marketed minn: Seqirus S.r.l. 
Ingredjent attiv: antiġeni tal-wiċċ tal-virus ta 'l-influwenza, inattivati: A / Vjet Nam / 1194/2004 (H5N1)

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Forsteo

Forsteo

Marketed minn: Eli Lilly Nederland B.V.
Ingredjent attiv: teriparatide

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fortacin

Fortacin

Marketed minn: Plethora Solutions Limited
Ingredjent attiv: lidocaine, prilocaine

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Forxiga

Forxiga

Marketed minn: AstraZeneca AB
Ingredjent attiv: dapagliflozin propanediol monohydrate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fosavance

Fosavance

Marketed minn: Merck Sharp & Dohme B.V.
Ingredjent attiv: alendronic acid, colecalciferol

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Foscan

Foscan

Marketed minn: Biolitec Pharma Ltd
Ingredjent attiv: temoporfin

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Fuzeon

Fuzeon

Marketed minn: Roche Registration GmbH
Ingredjent attiv: enfuvirtide

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency